Rx Marketing Spend Does Exceed R&D, AstraZeneca CEO Says

Drug companies can no longer argue that they spend more on research & development than on marketing, AstraZeneca CEO Tom McKillop maintained during the Pharmaceutical Leadership Forum Nov. 16 in Washington, D.C